RNR

Exploring RenaissanceRe (RNR) as an Investment Opportunity

Today we're going to take a closer look at Large-Cap Finance company RenaissanceRe, whose shares are currently trading at $254.79. We've been asking ourselves whether the company is under or over valued at today's prices... let's perform a brief value analysis to find out!

RenaissanceRe Is Potentially Undervalued and Trades Below Its Graham Number:

RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 19.48 and an average price to book (P/B) ratio of 1.85. In contrast, RenaissanceRe has a trailing 12 month P/E ratio of 4.9 and a P/B ratio of 1.42.

RenaissanceRe's PEG ratio is 2.56, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Exceptional EPS Growth and Generally Positive Cash Flows:

2018 2019 2020 2021 2022 2023
Revenue (M) $2,075 $4,202 $5,172 $5,278 $5,060 $9,135
Interest Income (M) $47 $58 $50 $48 $48 $73
Operating Margins 13% 23% 19% -2% -24% 34%
Net Margins 11% 18% 15% -1% -21% 28%
Net Income (M) $227 $749 $762 -$40 -$1,061 $2,561
Depreciation & Amort. (M) $0 -$59 $17 -$21 -$27 -$135
Diluted Shares (M) 40 44 50 47 43 48
Earnings Per Share $4.91 $16.29 $15.31 -$1.57 -$25.5 $52.27
EPS Growth n/a 231.77% -6.02% -110.25% -1524.2% 304.98%
Avg. Price $124.02 $164.47 $167.51 $154.17 $151.55 $254.79
P/E Ratio 25.26 10.08 10.92 -98.2 -5.94 4.86
Free Cash Flow (M) $1,222 $2,137 $1,993 $1,235 $1,604 $1,912
EV / EBITDA 18.45 6.77 6.71 -76.55 -5.57 3.46
Total Debt (M) $991 $1,384 $1,136 $1,168 $1,170 $1,959
Net Debt / EBITDA -0.44 0.0 -0.59 7.42 0.02 0.03

RenaissanceRe has strong operating margins with a positive growth rate and exceptional EPS growth. Additionally, the company's financial statements display low leverage levels and generally positive cash flows.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS